CN113041324A - 一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法 - Google Patents
一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法 Download PDFInfo
- Publication number
- CN113041324A CN113041324A CN202110457253.1A CN202110457253A CN113041324A CN 113041324 A CN113041324 A CN 113041324A CN 202110457253 A CN202110457253 A CN 202110457253A CN 113041324 A CN113041324 A CN 113041324A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 99
- 210000004369 blood Anatomy 0.000 title claims abstract description 98
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 230000007812 deficiency Effects 0.000 title claims abstract description 64
- 208000007342 Diabetic Nephropathies Diseases 0.000 title claims abstract description 53
- 208000033679 diabetic kidney disease Diseases 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 23
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 19
- 241000545744 Hirudinea Species 0.000 claims abstract description 19
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 19
- 240000008042 Zea mays Species 0.000 claims abstract description 19
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 18
- 235000005822 corn Nutrition 0.000 claims abstract description 18
- 235000006533 astragalus Nutrition 0.000 claims abstract description 17
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 14
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 14
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 12
- 241000628997 Flos Species 0.000 claims abstract description 7
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 4
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 4
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 4
- 241001598107 Imperata Species 0.000 claims description 22
- 244000131316 Panax pseudoginseng Species 0.000 claims description 20
- 244000025254 Cannabis sativa Species 0.000 claims description 19
- 241000382455 Angelica sinensis Species 0.000 claims description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims description 16
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 16
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 16
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 16
- 240000006079 Schisandra chinensis Species 0.000 claims description 16
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 16
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 15
- 235000011477 liquorice Nutrition 0.000 claims description 15
- 244000281702 Dioscorea villosa Species 0.000 claims description 13
- 235000004879 dioscorea Nutrition 0.000 claims description 13
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 8
- 241000045403 Astragalus propinquus Species 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 241000237903 Hirudo Species 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims 4
- 241000304195 Salvia miltiorrhiza Species 0.000 claims 4
- 235000005903 Dioscorea Nutrition 0.000 claims 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims 1
- 235000000504 Dioscorea villosa Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 40
- 230000001737 promoting effect Effects 0.000 abstract description 21
- 210000000952 spleen Anatomy 0.000 abstract description 18
- 208000002193 Pain Diseases 0.000 abstract description 14
- 235000009508 confectionery Nutrition 0.000 abstract description 12
- 210000002216 heart Anatomy 0.000 abstract description 12
- 241001061264 Astragalus Species 0.000 abstract description 10
- 238000005728 strengthening Methods 0.000 abstract description 10
- 210000004233 talus Anatomy 0.000 abstract description 10
- 208000004880 Polyuria Diseases 0.000 abstract description 9
- 230000003213 activating effect Effects 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 206010030113 Oedema Diseases 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 210000001124 body fluid Anatomy 0.000 abstract description 8
- 239000010839 body fluid Substances 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 210000002784 stomach Anatomy 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 230000035922 thirst Effects 0.000 abstract description 7
- 230000001939 inductive effect Effects 0.000 abstract description 5
- 238000010926 purge Methods 0.000 abstract description 5
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract description 4
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract description 4
- 230000001914 calming effect Effects 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 4
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract description 4
- 238000010791 quenching Methods 0.000 abstract description 4
- 230000000171 quenching effect Effects 0.000 abstract description 4
- 206010039424 Salivary hypersecretion Diseases 0.000 abstract description 3
- 208000026451 salivation Diseases 0.000 abstract description 3
- 240000007171 Imperata cylindrica Species 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 240000007164 Salvia officinalis Species 0.000 description 9
- 235000005412 red sage Nutrition 0.000 description 8
- 241000218202 Coptis Species 0.000 description 7
- 235000002991 Coptis groenlandica Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 229940107666 astragalus root Drugs 0.000 description 6
- 244000132619 red sage Species 0.000 description 6
- 230000010415 tropism Effects 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 241001165494 Rhodiola Species 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 206010036067 polydipsia Diseases 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 235000015961 tonic Nutrition 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 229960000716 tonics Drugs 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006083 Hypokinesia Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 2
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 206010061876 Obstruction Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000011279 abdominal lump Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000058061 Glucose Transporter Type 4 Human genes 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 101150037263 PIP2 gene Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 108091006300 SLC2A4 Proteins 0.000 description 1
- 101100262439 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UBA2 gene Proteins 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 208000003836 bluetongue Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical compound [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000032598 susceptibility microvascular complications of diabetes Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229930189533 tanshinol Natural products 0.000 description 1
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N tanshinone IIA Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法。该中药组合物是基于“滋阴清热、补肾健脾、益气养阴、活血化瘀”的理念治疗气虚血瘀型糖尿病肾病。丹参、赤芍、红花、三七粉用于助当归活血祛瘀、破癥散结;红人参、黄芪、淮山药具有补中益气、止渴、健脾益气、养血生津的作用配伍黄连清热泻火;红景天益气活血,通络止痛;玉米须利水消肿;知母、麦冬、黄精养阴生津;五味子收敛固涩、益气生津、补肾宁心;甘草调和诸药。另外,水蛭破瘀血而不伤新血,专入血分而不伤气分;白茅根的作用为甘寒而不伤胃,利水而不伤阴。该中药组合物具有治疗效果好,疗程短,成本低廉,制备方法简单等优点。
Description
技术领域
本发明涉及中医药技术领域,尤其涉及一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法。
背景技术
近年来,随着人们生活饮食习惯的改变和人口的老龄化,糖尿病的发病率有显著上升的趋势。
糖尿病是多种病因导致的、以慢性高血糖为特征的代谢性疾病,属于中医的“消渴”范畴,临床表现为多饮、多食、多尿及体重下降。糖尿病存在多种并发症,且并发症具有致命性。其中,糖尿病肾病是糖尿病的主要慢性微血管并发症之一,也是导致终末期肾功能衰竭的重要原因。因此,对于糖尿病肾病一定要早发现早治疗,以避免肾功能衰竭。
目前,糖尿病肾病尚缺少行业公认的中医辨证诊疗标准,临床上针对糖尿病治疗的中医辨证施治方案所拟定的中药组方品类繁杂,临床疗效不一,且治疗效果差。
发明内容
本发明提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法,以解决现有治疗气虚血瘀型糖尿病肾病的中药制剂存在的治疗效果差的问题。
本发明提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料包括当归、丹参、赤芍、红花、三七粉、红人参、黄芪、淮山药、黄连、红景天、玉米须、知母、麦冬、黄精、五味子、甘草、水蛭、白茅根,其中,各中药组成成分在中药组合物中具有以下特性:
当归:类别:补虚药。性味归经:甘、辛,温;归肝、心、脾经。功能主治:补血活血,调经止痛,润肠通便。研究表明,当归穴位注射,止痛效果显着,并且具有松弛肌肉,降低软组织的炎症性反应,及改善末梢神经和血管功能等作用。
丹参:类别:活血化瘀药。性味归经:苦,微寒。归心、肝经。功能主治:祛瘀止痛,活血通经,清心除烦。观察中药丹参的水溶性成分丹参素对其微血管及血浆乳酸含量的影响,结果表明丹参的水溶性成分丹参素改善局部组织微循环的血液灌流,血浆乳酸含量的变化与微循环障碍程度有关,也是反映细胞代谢障碍的指标之一。丹参及丹参素具有改善微循环障碍,从而改善细胞缺血缺氧所致的代谢障碍的作用。并且丹参酮ⅡA可降低血小板中PIP2水平,从而发挥抗血小板聚集的作用。
赤芍:味苦,性微寒;具有清热凉血,散瘀止痛额额的功效,主治热入营血,温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,瘾瘕腹痛,跌扑损伤,痈肿疮疡。
红花:味辛,性温;具有活血通经,散瘀止痛的功效,主治经闭,痛经,恶露不行,症瘕痞块,胸痹心痛,瘀滞腹痛,胸胁刺痛,跌扑损伤,疮疡肿痛。
三七粉:性温,味苦回甜,具有补血,去瘀损,止血衄,能通能补的功效。
红人参:类别:补虚药。性味归经:甘、微苦,平。归脾、肺、心经。功能主治:大补元气,复脉固脱,补脾益肺,生津,安神。人参皂甙除能改善糖尿病患者全身症状外,还有轻微降血糖作用,并与胰岛素有协同作用。
黄芪:类别:补虚药。性味归经:甘,微温。归肺、脾、肝、肾经。功能主治:益气固表、敛汗固脱、托疮生肌、利水消肿。研究表明,黄芪多糖具有强心扩血管的作用,可使全身末梢血管扩张,皮肤循环畅盛,此外黄芪还具有降血糖的作用。
淮山药:主治脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴。
黄连:类别:清热药。性味归经:苦,寒;归心、脾、胃、胆、大肠经。功能主治:清热燥湿,泻火解毒。黄连素可以促进AMPK磷酸化,从而激活AMPK/GLUT4信号通路,促进细胞对葡萄糖的摄取能力,可有改善糖尿病胰岛素抵抗的作用。
红景天:味甘,性寒,具有益气活血,通脉平喘的功效,主治气虚血瘀,胸痹心痛,中风偏瘫,倦怠气喘。
玉米须:味甘、淡,性平,具有利尿消肿、清肝利胆的功效,主治水肿,小便淋沥,黄疸,胆囊炎,胆结石,高血压,糖尿病,乳汁不通。
知母:味苦,性寒,具有清热泻火,滋阴润燥的功效,主治热病烦渴,肺热燥咳,骨蒸潮热,内热消渴,肠燥便秘。
麦冬:味甘,微苦,性微寒,具有养阴生津,润肺止咳的功效,主治肺胃阴虚之津少口渴、干咳咯血;心阴不足之心悸易惊及热病后期热伤津液。
黄精:味甘,性平,具有补气养阴,健脾,润肺,益肾的功效,主治脾胃气虚,体倦乏力,胃阴不足,口干食少,肺虚燥咳,劳嗽咳血,精血不足,腰膝酸软,须发早白,内热消渴。
五味子:味酸、甘,性温,具有收敛固涩,益气生津,补肾宁心的功效,主治久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗盗汗,津伤口渴,内热消渴,心悸失眠。
甘草:类别:补虚药。性味归经:甘,平;归心、肺、脾、胃经。功能主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。
水蛭:味咸、苦,性平,具有破血通经,逐瘀消症的功效,主治血瘀经闭,瘾瘕痞块,中风偏瘫,跌扑损伤。
白茅根:味甘,性寒,具有凉血止血,清热利尿的功效,主治血热吐血,衄血,尿血,热病烦渴,肺热咳嗽,胃热呕吐,湿热黄疸,水肿尿少,热淋涩痛。
在本申请提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物中,该中药组合物的制备原料按照重量份数包括当归15-25份、丹参25-35份、赤芍10-20份、红花8-18份、三七粉1-10份、红人参10-20份、黄芪25-35份、淮山药10-20份、黄连10-20份、红景天25-35份、玉米须25-35份、知母5-15份、麦冬10-20份、黄精25-35份、五味子5-15份、甘草5-15份、水蛭1-10份、白茅根25-35份。较为优选地,该中药组合物的制备原料按照重量份数包括当归18-22份、丹参26-32份、赤芍12-18份、红花10-15份、三七粉3-8份、红人参12-18份、黄芪27-34份、淮山药12-18份、黄连12-18份、红景天28-32份、玉米须28-32份、知母8-12份、麦冬13-18份、黄精28-33份、五味子8-12份、甘草8-12份、水蛭4-8份、白茅根26-32份。最为优选的,该中药组合物的制备原料按照重量份数包括当归20份、丹参30份、赤芍15份、红花12份、三七粉5份、红人参15份、黄芪30份、淮山药15份、黄连15份、红景天30份、玉米须30份、知母10份、麦冬15份、黄精30份、五味子10份、甘草10份、水蛭6份、白茅根30份。
在本申请提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物中,该中药组合物可以制备为汤剂。
基于本申请提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请还提供用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法包括:
S01:将当归、丹参、赤芍、红花、三七粉、红人参、黄芪、淮山药、黄连、红景天、玉米须、知母、麦冬、黄精、五味子、甘草、水蛭、白茅根烘干,得到干燥混合物。
将清洗后的当归、丹参、赤芍、红花、三七粉、红人参、黄芪、淮山药、黄连、红景天、玉米须、知母、麦冬、黄精、五味子、甘草、水蛭、白茅根放入烘干箱中烘干,以使水分降低,形成干燥混合物。
S02:所述干燥混合物与水按照质量比1:(2-4)混合后浸泡1-2h。
S03:浸泡结束后,大火加热至沸腾3-5min,文火熬煮2-3h;过滤后得到中药组合物。
干燥混合物浸泡结束后,大火加热。大火沸腾3-5min后,改为文火熬煮,熬煮时间为2-3h。文火熬煮结束后采用300-800滤网过滤,并收集滤液,得到中药组合物。
本发明的实施例提供的技术方案可以包括以下有益效果:
本发明提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法,该中药组合物的制备原料包括当归、丹参、赤芍、红花、三七粉、红人参、黄芪、淮山药、黄连、红景天、玉米须、知母、麦冬、黄精、五味子、甘草、水蛭、白茅根。该中药组合物是基于“滋阴清热、补肾健脾、益气养阴、活血化瘀”的理念治疗气虚血瘀型糖尿病肾病。其中,丹参、赤芍、红花、三七粉具有破血、逐瘀、通经的作用,用于助当归活血祛瘀、破癥散结;红人参、黄芪、淮山药具有补中益气、止渴、健脾益气、养血生津的作用,其中黄芪甘温升发,功擅补气,为补药之长,能补益三焦,表里脏腑诸气;配伍黄连清热泻火;红景天益气活血,通络止痛;玉米须利水消肿;知母、麦冬、黄精养阴生津;五味子收敛固涩、益气生津、补肾宁心;甘草调和诸药。另外,水蛭破瘀血而不伤新血,专入血分而不伤气分;白茅根的作用为甘寒而不伤胃,利水而不伤阴。由此,全方共奏补气活血之效,并兼顾益阴健脾等功效。本申请提供的中药组合物及制备方法具有治疗效果好,疗程短,成本低廉,制备方法简单等优点。
应当理解的是,以上的一般描述和后文的细节描述仅是示例性和解释性的,并不能限制本发明。
具体实施方式
临床实践中我们发现,气虚血瘀型糖尿病肾病的病机为气虚血瘀,因此,本申请中的中药组合物是基于“滋阴清热、补肾健脾、益气养阴、活血化瘀”的理念治疗气虚血瘀型糖尿病肾病。其中,丹参、赤芍、红花、三七粉具有破血、逐瘀、通经的作用,用于助当归活血祛瘀、破癥散结;红人参、黄芪、淮山药具有补中益气、止渴、健脾益气、养血生津的作用,其中黄芪甘温升发,功擅补气,为补药之长,能补益三焦,表里脏腑诸气;配伍黄连清热泻火;红景天益气活血,通络止痛;玉米须利水消肿;知母、麦冬、黄精养阴生津;五味子收敛固涩、益气生津、补肾宁心;甘草调和诸药。另外,水蛭破瘀血而不伤新血,专入血分而不伤气分;白茅根的作用为甘寒而不伤胃,利水而不伤阴。由此,全方共奏补气活血之效,并兼顾益阴健脾等功效。
本申请提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法,下述以具体实施例的形式进行描述,但这并不限定本申请的保护范围。
实施例1
本申请实施例提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料按照重量份数包括当归20份、丹参30份、赤芍15份、红花12份、三七粉5份、红人参15份、黄芪30份、淮山药15份、黄连15份、红景天30份、玉米须30份、知母10份、麦冬15份、黄精30份、五味子10份、甘草10份、水蛭6份、白茅根30份。
基于上述本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请实施例还提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法包括:
S101:将清洗后的当归、丹参、赤芍、红花、三七粉、红人参、黄芪、淮山药、黄连、红景天、玉米须、知母、麦冬、黄精、五味子、甘草、水蛭、白茅根放入烘干箱中烘干,以使水分降低,形成干燥混合物。
S102:干燥混合物与水按照质量比1:(2-4)混合后浸泡1-2h。
S103:浸泡结束后,大火加热至沸腾3-5min,文火熬煮2-3h;过滤后得到中药组合物。
实施例2
本申请实施例提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料按照重量份数包括当归15份、丹参25份、赤芍10份、红花8份、三七粉1份、红人参10份、黄芪25份、淮山药10份、黄连10份、红景天25份、玉米须25份、知母5份、麦冬10份、黄精25份、五味子5份、甘草5份、水蛭1份、白茅根25份。
基于上述本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请实施例还提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法请参考实施例1。
实施例3
本申请实施例提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料按照重量份数包括当归25份、丹参35份、赤芍20份、红花18份、三七粉10份、红人参20份、黄芪35份、淮山药20份、黄连20份、红景天35份、玉米须35份、知母15份、麦冬20份、黄精35份、五味子15份、甘草15份、水蛭10份、白茅根35份。
基于上述本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请实施例还提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法请参考实施例1。
实施例4
本申请实施例提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料按照重量份数包括当归22份、丹参28份、赤芍18份、红花13份、三七粉7份、红人参16份、黄芪32份、淮山药16份、黄连17份、红景天29份、玉米须30份、知母12份、麦冬15份、黄精28份、五味子10份、甘草10份、水蛭6份、白茅根33份。
基于上述本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请实施例还提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法请参考实施例1。
实施例5
本申请实施例提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料按照重量份数包括当归18份、丹参26份、赤芍12份、红花10份、三七粉3份、红人参12份、黄芪27份、淮山药12份、黄连12份、红景天28-份、玉米须28份、知母8份、麦冬13份、黄精28份、五味子8份、甘草8份、水蛭4份、白茅根26份。
基于上述本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请实施例还提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法请参考实施例1。
实施例6
本申请实施例提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料按照重量份数包括当归22份、丹参32份、赤芍18份、红花15份、三七粉8份、红人参18份、黄芪34份、淮山药18份、黄连18份、红景天32份、玉米须32份、知母12份、麦冬18份、黄精33份、五味子12份、甘草12份、水蛭8份、白茅根32份。
基于上述本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请实施例还提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法请参考实施例1。
实施例7
本申请实施例提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,该中药组合物的制备原料按照重量份数包括当归21份、丹参28份、赤芍16份、红花14份、三七粉4份、红人参15份、黄芪29份、淮山药17份、黄连16份、红景天29份、玉米须31份、知母9份、麦冬16份、黄精31份、五味子9份、甘草10份、水蛭7份、白茅根29份。
基于上述本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物,本申请实施例还提供一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,该方法请参考实施例1。
为说明本申请实施例提供的用于治疗气虚血瘀型糖尿病肾病的中药组合物能够用于治疗气虚血瘀型糖尿病肾病,且具有良好的疗效,本申请实施例以实施例1所制备的中药组合物为例进行临床试验,具体试验过程及结果如下。
试验例1:
患者男,57岁,糖尿病病史7年,有肾功能不全史4年,常常感到腰膝酸软,乏力,气少懒言,口干多饮,失眠多梦,夜尿多,心烦。舌青紫,苔少,有齿痕,脉沉细。空腹血糖8.1mmol/L,餐后2h血糖15.2mmol/L,24小时定量尿蛋白4.2g、尿蛋白肌酐比值为57mg/mmo1,此患者辩证为气虚血瘀型糖尿病肾病。采用实施例1所示的药方服用1个疗程后,症状减轻,继续服用1个疗程巩固,空腹血糖小于7.0mmol/L,尿蛋白正常。继服上方服用近2个月,血糖值正常,肾功正常。
试验例2:
患者男,72岁,糖尿病病史15年,8年高血压病史,近期尿频而量多,倦怠乏力,伴随出现腰酸痛,口干多饮,气短、多汗,纳差,视物模糊,双下肢麻木水肿,舌暗红。舌边有齿痕,苔薄白,脉沉迟。空腹血糖8mmol/L,餐后2h血糖13.8mmo1/L,24小时定量尿蛋白6.4g,尿蛋白肌酐比值为63mg/mmo1,此患者辩证为气虚血瘀型糖尿病肾病。采用实施例1所示的药方7剂,每日一剂,水煎服,早晚分服,症状减轻,继服上方服用近2个月,血糖和尿糖恢复正常,自觉症状基本消失。
上述两个试验例说明,本申请实施例提供的中药组合物能够有效治疗气虚血瘀型糖尿病肾病,且治疗效果好,疗程短,成本低廉,制备方法简单。
本领域技术人员在考虑说明书及实践这里发明的公开后,将容易想到本发明的其它实施方案。本申请旨在涵盖本发明的任何变型、用途或者适应性变化,这些变型、用途或者适应性变化遵循本发明的一般性原理并包括本发明未公开的本技术领域中的公知常识或惯用技术手段。说明书和实施例仅被视为示例性的,本发明的真正范围和精神由下面的权利要求指出。
应当理解的是,诸如“第一”和“第二”等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。本发明并不局限于上面已经描述的精确结构,并且可以在不脱离其范围进行各种修改和改变。本发明的范围仅由所附的权利要求来限制。
Claims (7)
1.一种用于治疗气虚血瘀型糖尿病肾病的中药组合物,其特征在于,所述中药组合物的制备原料包括当归、丹参、赤芍、红花、三七粉、红人参、黄芪、淮山药、黄连、红景天、玉米须、知母、麦冬、黄精、五味子、甘草、水蛭、白茅根。
2.根据权利要求1所述的用于治疗气虚血瘀型糖尿病肾病的中药组合物,其特征在于,所述中药组合物的制备原料按照重量份数包括当归15-25份、丹参25-35份、赤芍10-20份、红花8-18份、三七粉1-10份、红人参10-20份、黄芪25-35份、淮山药10-20份、黄连10-20份、红景天25-35份、玉米须25-35份、知母5-15份、麦冬10-20份、黄精25-35份、五味子5-15份、甘草5-15份、水蛭1-10份、白茅根25-35份。
3.根据权利要求1所述的用于治疗气虚血瘀型糖尿病肾病的中药组合物,其特征在于,所述中药组合物的制备原料按照重量份数包括当归18-22份、丹参26-32份、赤芍12-18份、红花10-15份、三七粉3-8份、红人参12-18份、黄芪27-34份、淮山药12-18份、黄连12-18份、红景天28-32份、玉米须28-32份、知母8-12份、麦冬13-18份、黄精28-33份、五味子8-12份、甘草8-12份、水蛭4-8份、白茅根26-32份。
4.根据权利要求1所述的用于治疗气虚血瘀型糖尿病肾病的中药组合物,其特征在于,所述中药组合物的制备原料按照重量份数包括当归20份、丹参30份、赤芍15份、红花12份、三七粉5份、红人参15份、黄芪30份、淮山药15份、黄连15份、红景天30份、玉米须30份、知母10份、麦冬15份、黄精30份、五味子10份、甘草10份、水蛭6份、白茅根30份。
5.根据权利要求1-4中任一项所述的用于治疗气虚血瘀型糖尿病肾病的中药组合物,其特征在于,所述中药组合物的制剂为汤剂。
6.一种用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,其特征在于,包括:
将当归、丹参、赤芍、红花、三七粉、红人参、黄芪、淮山药、黄连、红景天、玉米须、知母、麦冬、黄精、五味子、甘草、水蛭、白茅根烘干,得到干燥混合物;
所述干燥混合物与水按照质量比1:(2-4)混合后浸泡1-2h;
浸泡结束后,大火加热至沸腾3-5min,文火熬煮2-3h;过滤后得到中药组合物。
7.根据权利要求6所述的用于治疗气虚血瘀型糖尿病肾病的中药组合物的制备方法,其特征在于,采用300-800目滤网过滤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110457253.1A CN113041324A (zh) | 2021-04-27 | 2021-04-27 | 一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110457253.1A CN113041324A (zh) | 2021-04-27 | 2021-04-27 | 一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113041324A true CN113041324A (zh) | 2021-06-29 |
Family
ID=76520535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110457253.1A Pending CN113041324A (zh) | 2021-04-27 | 2021-04-27 | 一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113041324A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111449244A (zh) * | 2020-04-15 | 2020-07-28 | 南京中医药大学 | 一种改善气虚血瘀的固体饮料及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108853433A (zh) * | 2018-08-31 | 2018-11-23 | 阴永辉 | 一种治疗糖尿病肾病的中药及其制备方法 |
-
2021
- 2021-04-27 CN CN202110457253.1A patent/CN113041324A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108853433A (zh) * | 2018-08-31 | 2018-11-23 | 阴永辉 | 一种治疗糖尿病肾病的中药及其制备方法 |
Non-Patent Citations (3)
Title |
---|
张莹雯: "自拟糖肾宁治疗糖尿病肾病52例", 《黑龙江中医药》 * |
李艳红等: "中西医结合对糖尿病肾病治疗疗效观察", 《中国实用医药》 * |
谌洁等: "益气养阴活血方治疗糖尿病肾病30例临床研究", 《中医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111449244A (zh) * | 2020-04-15 | 2020-07-28 | 南京中医药大学 | 一种改善气虚血瘀的固体饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103055116B (zh) | 一种治疗痤疮的中药组合物 | |
CN101366908A (zh) | 一种治疗糖尿病的中药 | |
CN103301356A (zh) | 一种慢性肾衰竭用灌肠液制备方法 | |
CN113041324A (zh) | 一种用于治疗气虚血瘀型糖尿病肾病的中药组合物及制备方法 | |
CN104225166A (zh) | 一种治疗闭经的中药组合物及其制备方法 | |
CN103301355A (zh) | 一种慢性肾衰竭结肠透析液制备方法 | |
CN103330868A (zh) | 一种慢性肾衰竭用肠道给液 | |
CN101428114B (zh) | 一种治疗慢性乙肝、肝硬化和肝腹水的药物 | |
CN105497811A (zh) | 一种治疗肝硬化的中药组合物及其制备工艺 | |
CN104147526A (zh) | 一种治疗黄疸型肝炎的中药颗粒及其制备方法 | |
CN1772180A (zh) | 治疗阴虚低热症的中草药汤剂及制备方法 | |
CN113082115A (zh) | 一种用于治疗糖尿病周边神经病变的中药组合物及制备方法 | |
CN101658652A (zh) | 一种治疗慢性阑尾炎的中药制剂 | |
CN1149095C (zh) | 一种治疗小儿先天性心脏病的中药 | |
CN104740182A (zh) | 一种治疗牙周炎的中药组合物 | |
CN102614420A (zh) | 一种治疗萎缩性舌炎的中药制剂 | |
CN103341095A (zh) | 一种慢性肾衰竭用灌肠液 | |
CN116983359B (zh) | 治疗糖尿病合并冠心病稳定型心绞痛的药物组合物 | |
CN102988890A (zh) | 治疗黄褐斑的纯中药制剂 | |
CN101985027A (zh) | 治疗肝硬化的中草药 | |
CN106581476A (zh) | 一种治疗糖尿病的中药配方 | |
CN104873854A (zh) | 一种用于小动脉性肾硬化症的中药制剂及其制备方法 | |
CN116898927A (zh) | 一种基于三七果梗提取物和黄芪的中药组合物及其制备工艺 | |
CN116983359A (zh) | 治疗糖尿病合并冠心病稳定型心绞痛的药物组合物 | |
CN115487264A (zh) | 一种化痰祛瘀组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210629 |